SCHEMBL19303535

SCHEMBL19303535

COc1ccc(-c2cc(=O)c3c(N=O)c(O)c(O)cc3o2)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FLT3 P36888 6/20 0.69
▸ KMT2A Q03164 5/20 0.69
▸ MAPT P10636 5/20 0.69
▸ MEN1 O00255 4/20 0.69
▸ NPC1 O15118 4/20 0.69
▸ RAB9A P51151 3/20 0.69
▸ POLB P06746 2/20 0.69
▸ KIT P10721 1/20 0.69
▸ NFKB1 P19838 1/20 0.69
▸ OPRD1 P41143 1/20 0.69
▸ NFKB2 Q00653 1/20 0.69
▸ RELA Q04206 1/20 0.69
▸ MAOB P27338 3/20 0.67
▸ CYP19A1 P11511 1/20 0.67
▸ ALDH1A1 P00352 4/20 0.65
▸ CYP3A4 P08684 3/20 0.65
▸ IP6K2 Q9UHH9 2/20 0.65
▸ TDP1 Q9NUW8 2/20 0.65
▸ CYP2C9 P11712 2/20 0.65
▸ CYP2C19 P33261 2/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6242511 0.86 KMT2A (0.81) FLT3KMT2AMAPTMEN1NPC1
SCHEMBL28732976 0.84 FLT3 (0.81) FLT3KMT2AMAPTMEN1NPC1
SCHEMBL29504103 0.84 FLT3 (0.81) FLT3KMT2AMAPTMEN1NPC1
SCHEMBL20664416 0.83 ALDH1A1 (0.69) FLT3KMT2AMAPTMEN1NPC1
Pectolinarigenin SCHEMBL29606971 0.81 MAPT (1.00) FLT3KMT2AMAPTMEN1NPC1
Pectolinarigenin SCHEMBL243686 0.81 MAPT (1.00) FLT3KMT2AMAPTMEN1NPC1
Apigenin Dimethylether SCHEMBL29392759 0.81 MAOB (1.00) FLT3KMT2AMAPTMEN1NPC1
Apigenin Dimethylether SCHEMBL1176691 0.81 MAOB (1.00) FLT3KMT2AMAPTMEN1NPC1
SCHEMBL8063178 0.80 FLT3 (0.83) FLT3KMT2AMAPTMEN1NPC1
SCHEMBL28592818 0.80 MAPT (0.74) FLT3KMT2AMAPTMEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017146332-A1 NOVEL USE OF CHROMONE DERIVATIVE AS PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING FIBROSIS BY USING EPITHELIAL-MESENCHYMAL TRANSITION INHIBITORY ACTIVITY THEREOF (주)오스티오뉴로젠 2017-08-31 — — WO disclosed
Send feedback